  | Ternad, I., Penninckx, S., Lecomte, V., Vangijzegem, T., Conrard, L., Lucas, S., A.-C. Heuskin, Michiels, C., Muller, R., Stanicki, D., & Laurent, S. (2023). Advances in the Mechanistic Understanding of Iron Oxide Nanoparticles’ Radiosensitizing Properties. Nanomaterials.  Peer reviewed |
 | Vangijzegem, T., Lecomte, V., Ternad, I., Van leuven, L., Muller, R., Stanicki, D., & Laurent, S. (2023). « Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy. Pharmaceutics. doi:10.3390/pharmaceutics15010236 Peer Reviewed verified by ORBi |
  | Lanfranco, A., Alberti, D., Parisotto, S., Renzi, P., LECOMTE, V., Geninatti Crich, S., & Deagostino, A. (06 July 2022). Biotinylation of a MRI/Gd BNCT theranostic agent to access a novel tumour-targeted delivery system. Organic and Biomolecular Chemistry, 20 (26), 5342 - 5354. doi:10.1039/d2ob00764a Peer Reviewed verified by ORBi |
 | Vangijzegem, T., Van leuven, L., Ternad, I., Lecomte, V., Muller, R., Stanicki, D., & Laurent, S. (October 2024). Radiosensitizing Effect of Iron Oxide Nanoparticles (IONPs) : Towards Improved Radiotherapy Outcomes [Paper presentation]. CMR, Oslo, Norway. Peer reviewed |
Ternad, I., Stanicki, D., Vangijzegem, T., Lecomte, V., H-F. Renard, A-C Heuskin, C. Michiels, S. Penninckx, Muller, R., & Laurent, S. (2024). Exploring the Radiosensitizing Potential of Magnetic Nanoparticles [Paper presentation]. Journée scientifique d'impact, Bordeaux, France. Peer reviewed |
 | Ternad, I., Stanicki, D., Vangijzegem, T., Lecomte, V., Renard, H.-F., Penninckx, S., Muller, R., Lucas, S., & Laurent, S. (17 October 2024). The radiosensitizing potential of iron oxide nanoparticles [Poster presentation]. SRC scientific day, Bioinspired chemistry : from molecules to cells, Mons, Belgium. Peer reviewed |
 | Vangijzegem, T., Van leuven, L., Ternad, I., Lecomte, V., Muller, R., Stanicki, D., & Laurent, S. (2024). Radiosensitizing Effect of Iron Oxide Nanoparticles: Towards Improved Radiotherapy Outcomes [Poster presentation]. Radiosensitizing Effect of Iron Oxide , Towards Improved Radiotherapy Outcomes. Peer reviewed |
| Lecomte, V., Ternad, I., Stanicki, D., Vangijzegem, T., Boutry, S., Muller, R., Michiels C., & Laurent, S. (2024). Radiosensitizing Magnetic Nanoparticles as a Targeted Theragnostic Agent for Cancer Therapy [Poster presentation]. The future of Molecular MR 2024, orléans, France. Peer reviewed |
Ternad, I., Stanicki, D., Vangijzegem, T., Lecomte, V., H-F.Renard, S. Penninckx, Larbanoix, L., Muller, R., & Laurent, S. (2024). Exploring the Radiosensitizing Potential of magnetic Nanoparticles [Poster presentation]. Jeune chimiste de la SRC. Peer reviewed |
Ternad, I., Stanicki, D., Vangijzegem, T., Lecomte, V., H-F.Renard, S. Penninckx, Muller, R., S. Lucas, & Laurent, S. (2024). Exploring the Radiosensitizing Potential of Iron Oxide Nanoparticles [Poster presentation]. ESMI, Porto, Portugal. Peer reviewed |
Ternad, I., Lecomte, V., Stanicki, D., Vangijzegem, T., S. Penninckx, Muller, R., Lucas S., & Laurent, S. (2024). Iron oxide nanoparticles as a theranostic agent [Poster presentation]. EDT-CHIM 2024, Liège, Belgium. Peer reviewed |
 | Lecomte, V., Ternad, I., Stanicki, D., Vangijzegem, T., Boutry, S., Muller, R., Michiels, C., & Laurent, S. (2024). Targeted radiosensitizingmagnetic nanoparticles as a therapeutic agent for cancer therapy [Poster presentation]. SRC scientific day, Bioinspired chemistry : from molecules to cells, Mons, Belgium. Peer reviewed |
| Lecomte, V., Ternad, I., Stanicki, D., Vangijzegem, T., Penninckx S., Muller, R., Lucas S., & Laurent, S. (2023). Radiosensitizing Magnetic Nanoparticles as a Targeted Theranostic Agent for Anti-Cancer Therapy [Poster presentation]. YBMRS 2023, blanckenberge, Belgium. Peer reviewed |
Ternad, I., Penninckx, S., Lecomte, V., Vangijzegem, T., Garifo, S., L. Conrard, S. Lucas, A.-C. Heuskin, C. Michiels, Muller, R., Stanicki, D., & Laurent, S. (2023). Evaluation of Radiosensitizing Magnetic Nanoparticles as a Novel Theranostic Agent for Cancer Therapy [Poster presentation]. Poster communication presented at the European Molecular Imaging Meeting (EMIM 2023), 18th Annual Meeting of the European Society for Molecular Imaging, Salzburg, Austria. Peer reviewed |
Ternad, I., Lecomte, V., Stanicki, D., Vangijzegem, T., S. Penninckx, Muller, R., Laurent, S., & S. Lucas. (2023). Magnetic nanoparticles as theranostic agents [Poster presentation]. EDT chim, UMONS, MONS, Belgique. Peer reviewed |
Lecomte, V., Ternad, I., Stanicki, D., & Laurent, S. (2023). Evaluation of Radiosensitizing Magnetic Nanoparticles as a novel Theranostic Agent for the Therapy of Cancer [Poster presentation]. SRC Young Chemists’ Day, Mons. Peer reviewed |
Van leuven, L., Lecomte, V., Garifo, S., Vangijzegem, T., Stanicki, D., & Laurent, S. (2023). PEGylated nanoparticles functionalization by flow photochemistry approach” [Poster presentation]. SRC, Louvain-La-Neuve, Belgium. Peer reviewed |
Ternad, I., Stanicki, D., Vangijzegem, T., Boutry, S., Penninckx, S., Lecomte, V., Muller, R., Lucas, S., & Laurent, S. (03 May 2022). PEGylated Magnetic Particles for MRI and Radiotherapy Application [Poster presentation]. Flash talk and poster session presented at BMIC-DyMIC Imaging Congress, Anvers, Belgium. Peer reviewed |
